Ensysce Biosciences COO Jeffrey Millard resigns effective July 10, 2026

Ensysce Biosciences, Inc.

Jeffrey Millard resigned as Chief Operating Officer on July 10, 2026.
Resignation notice received and effective on the same date.
No replacement or interim COO has been announced.

item 5.02 item 9.01

Featured in Daily 8-K Digest

Selected #1 for 2026-07-15. Read digest

Ensysce Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-033360

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.